Sign in

Filings

Finds words inside filing documents. Searching NewAmsterdam Pharma Co N.V.'s filings · 49 documents indexed.

2 documents · 7 matches

  1. NAMS NewAmsterdam Pharma Co N.V. 10-K 2026-02-18

    Item 1A. Risk Factors

    material weaknesses. If we identify future material weaknesses, the accuracy and timing of our financial reporting may be adversely affected
    5 matches in this document
  2. NAMS NewAmsterdam Pharma Co N.V. 10-Q 2025-05-08

    Item 1A. Risk Factors

    material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further
    2 matches in this document

Page 1 of 1 · 2 documents